Objective: Pseudomyxoma peritonei (PMP) is a rare, chronic, relapsing, diagnostically challenging, and poorly understood disease characterized by disseminated mucinous ascites and peritoneal implants. PMP usually develops secondary to mucinous neoplasms of the appendix and/or the ovary. Only few reports of limited PMP were published. Case Report: We describe the case of a 53-year-old woman who presented with a limited mucinous collection in the pelvis seen on computed tomography and who underwent surgery for mucocele of the appendix, bilateral mucinous ovarian tumors, and single mucinous implant on the great omentum 16 years previously. Serum tumor markers: CEA was elevated and CA 19-9 was within the normal range. At surgery, a well-circumscribed collection of mucin was found in the pelvis, and removal of mucinous material with intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) and postoperative intraperitoneal irrigation with 5-fluorouracil was performed. Histological examination revealed disseminated peritoneal adenomucinosis according to Ronnett’s classification. After surgery, the patient has been free of recurrence for 2 years. Conclusion: Our case report highlights that PMP requires careful observation, as it might be detected after a long-term follow-up period post-appendectomy for appendiceal mucocele.

Keywords:
Pelvis, Pseudomyxoma, Recurrence, Localization
This content is only available via PDF.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.